DD250313A5 - Verfahren zur herstellung von neuen benzoesaeurederivaten - Google Patents
Verfahren zur herstellung von neuen benzoesaeurederivaten Download PDFInfo
- Publication number
- DD250313A5 DD250313A5 DD86289588A DD28958886A DD250313A5 DD 250313 A5 DD250313 A5 DD 250313A5 DD 86289588 A DD86289588 A DD 86289588A DD 28958886 A DD28958886 A DD 28958886A DD 250313 A5 DD250313 A5 DD 250313A5
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- formula
- group
- compound
- hydrogen
- same meaning
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/192—Radicals derived from carboxylic acids from aromatic carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
- C07C33/04—Acyclic alcohols with carbon-to-carbon triple bonds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C65/01—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups
- C07C65/19—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups having unsaturation outside the aromatic ring
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pulmonology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19853515278 DE3515278A1 (de) | 1985-04-27 | 1985-04-27 | Neue benzoesaeurederivate, diese enthaltende arzneimittel und verfahren zur herstellung dieser verbindungen und arzneimittel |
Publications (1)
Publication Number | Publication Date |
---|---|
DD250313A5 true DD250313A5 (de) | 1987-10-08 |
Family
ID=6269293
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DD86289588A DD250313A5 (de) | 1985-04-27 | 1986-04-24 | Verfahren zur herstellung von neuen benzoesaeurederivaten |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP0199985A3 (xx) |
JP (1) | JPS6242947A (xx) |
KR (1) | KR860008155A (xx) |
AU (1) | AU582433B2 (xx) |
DD (1) | DD250313A5 (xx) |
DE (1) | DE3515278A1 (xx) |
DK (1) | DK186286A (xx) |
ES (1) | ES8703402A1 (xx) |
FI (1) | FI861414A (xx) |
GR (1) | GR860442B (xx) |
HU (1) | HU196163B (xx) |
IL (1) | IL77989A (xx) |
PT (1) | PT82393B (xx) |
SU (1) | SU1450734A3 (xx) |
ZA (1) | ZA861490B (xx) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2642972B1 (fr) * | 1989-02-14 | 1994-08-05 | Inst Nat Sante Rech Med | Agents pour le diagnostic et le traitement des melanomes, derives halogenes aromatiques utilisables comme de tels agents et leur preparation |
DE4023742A1 (de) * | 1990-07-26 | 1992-01-30 | Gruenenthal Gmbh | Substituierte phenylacetylene, diese enthaltende arzneimittel und verfahren zur herstellung dieser verbindungen und arzneimittel |
DE4120698A1 (de) * | 1991-06-22 | 1992-12-24 | Gruenenthal Gmbh | Substituierte phenoxyalkanole und deren ester, diese verbindungen enthaltende arzneimittel und verfahren zur herstellung dieser verbindungen und arzneimittel |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES494769A0 (es) * | 1979-09-05 | 1981-07-16 | Glaxo Group Ltd | Un procedimiento para la pre-paracion de fenoxialcoxifenil- derivados. |
US4331683A (en) * | 1980-10-29 | 1982-05-25 | Pfizer Inc. | Carboxamide compounds as SRS-A antagonists |
DE3169761D1 (en) * | 1981-01-09 | 1985-05-09 | Fisons Plc | Phenoxy- and thiophenoxy compounds, methods for their preparation and pharmaceutical formulations containing them |
IE54269B1 (en) * | 1981-12-30 | 1989-08-02 | Ici America Inc | Pharmaceutically active phenylcarboxylic acid derivatives |
US4507498A (en) * | 1982-04-09 | 1985-03-26 | Hoffmann-La Roche Inc. | Phenoxycarboxylic acids |
DE3228629A1 (de) * | 1982-07-31 | 1984-02-02 | Reifenrath, Rainer Richard Otto, Dr., 3104 Unterlüß | Pharmazeutisches erzeugnis zur behandlung der atemwege und verfahren zu seiner herstellung |
IL69691A (en) * | 1982-09-23 | 1988-01-31 | Merck Frosst Canada Inc | Leukotriene antagonists,their preparation and pharmaceutical compositions containing them |
DD242802A1 (de) * | 1983-02-28 | 1987-02-11 | Univ Berlin Humboldt | Verfahren zur herstellung neuer w(2'-naphthoxy)-hydroxamsaeuren enthaltende pharmazeutische zubereitungen und ihren salzen |
US4539419A (en) * | 1983-05-02 | 1985-09-03 | Hoffmann-La Roche Inc. | Naphthalenyloxy substituted carboxylic acids |
US4499295A (en) * | 1983-05-09 | 1985-02-12 | G. D. Searle & Co. | Protease inhibitors |
-
1985
- 1985-04-27 DE DE19853515278 patent/DE3515278A1/de not_active Withdrawn
-
1986
- 1986-02-14 GR GR860442A patent/GR860442B/el unknown
- 1986-02-25 IL IL77989A patent/IL77989A/xx unknown
- 1986-02-27 ZA ZA861490A patent/ZA861490B/xx unknown
- 1986-03-24 EP EP86104007A patent/EP0199985A3/de not_active Withdrawn
- 1986-04-01 FI FI861414A patent/FI861414A/fi not_active Application Discontinuation
- 1986-04-04 ES ES553731A patent/ES8703402A1/es not_active Expired
- 1986-04-08 SU SU864027236A patent/SU1450734A3/ru active
- 1986-04-15 PT PT82393A patent/PT82393B/pt unknown
- 1986-04-18 AU AU56366/86A patent/AU582433B2/en not_active Expired - Fee Related
- 1986-04-23 DK DK186286A patent/DK186286A/da not_active Application Discontinuation
- 1986-04-24 DD DD86289588A patent/DD250313A5/de unknown
- 1986-04-25 HU HU861716A patent/HU196163B/hu not_active IP Right Cessation
- 1986-04-25 JP JP61095006A patent/JPS6242947A/ja active Pending
- 1986-04-26 KR KR1019860003288A patent/KR860008155A/ko not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP0199985A2 (de) | 1986-11-05 |
AU5636686A (en) | 1986-11-06 |
SU1450734A3 (ru) | 1989-01-07 |
HU196163B (en) | 1988-10-28 |
JPS6242947A (ja) | 1987-02-24 |
ZA861490B (en) | 1986-10-29 |
DK186286D0 (da) | 1986-04-23 |
AU582433B2 (en) | 1989-03-23 |
FI861414A0 (fi) | 1986-04-01 |
FI861414A (fi) | 1986-10-28 |
HUT40611A (en) | 1987-01-28 |
GR860442B (en) | 1986-06-16 |
KR860008155A (ko) | 1986-11-12 |
ES553731A0 (es) | 1987-02-16 |
PT82393B (de) | 1987-09-10 |
ES8703402A1 (es) | 1987-02-16 |
EP0199985A3 (de) | 1988-06-22 |
DE3515278A1 (de) | 1986-10-30 |
PT82393A (de) | 1986-05-01 |
IL77989A (en) | 1989-08-15 |
DK186286A (da) | 1986-10-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE2923815C2 (xx) | ||
DE69314718T2 (de) | Oxamidsäure-Derivate als hypocholesterämische Mittel | |
DE69928583T2 (de) | Tetrahydrochinolinderivate mit selektiver Aktivität für Retinoid X Rezeptoren | |
DE10110750A1 (de) | Neuartige Aminodicarbonsäurederivate mit pharmazeutischen Eigenschaften | |
DE10110749A1 (de) | Substituierte Aminodicarbonsäurederivate | |
DE19943634A1 (de) | Neuartige Dicarbonsäurederivate mit pharmazeutischen Eigenschaften | |
DE19943639A1 (de) | Dicarbonsäurederivate mit neuartigen pharmazeutischen Eigenschaften | |
DE4228201A1 (de) | Neue Leukotrien-B¶4¶-Antagonisten, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel | |
AT395421B (de) | Verfahren zur herstellung von neuen cyclopenthylethern | |
DE68920063T2 (de) | Derivate von Benzoesäure und Verfahren zu deren Herstellung. | |
EP0281943B1 (de) | Substituierte Pyridin-2,4-dicarbonsäure-Derivate, Verfahren zu ihrer Herstellung, Verwendung derselben sowie Arzneimittel auf Basis dieser Verbindungen | |
EP0468281B1 (de) | Substituierte Phenylacetylene, diese enthaltende Arzneimittel und Verfahren zur Herstellung dieser Verbindungen und Arzneimittel | |
DD250313A5 (de) | Verfahren zur herstellung von neuen benzoesaeurederivaten | |
EP0009777B1 (de) | Retinsäure- und 7,8-Dehydro-retinsäure-N-(carboxy)-phenyl-amide, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Mittel | |
EP0009776B1 (de) | N-Monohydroxypropylamide, N-Dihydroxypropylamide und deren Acetonoide der all-E- und 13-Z-Retinsäure, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Mittel | |
EP0202529B1 (de) | Neue Phenolderivate, diese enthaltende Arzneimittel und Verfahren zur Herstellung dieser Verbindungen und Arzneimittel | |
CH517066A (de) | Verfahren zur Herstellung von neuen Aryloxy- und Arylthioessigsäuren und ihren Alkali- und Erdalkalimetallsalzen | |
DE3819052A1 (de) | Neue sulfonamid-derivate, ihre herstellung und verwendung | |
EP0377896A2 (de) | Cyclooxygenase- und 5-Lipoxygenase-inhibierende Hydroxansäurederivate | |
EP0012801A1 (de) | 2-(1-Phenyl-2,5-cyclohexadienyl)-äthylaminderivate, Verfahren zu deren Herstellung, deren Verwendung als pharmazeutische Wirkstoffe sowie diese enthaltende Arzneimittel | |
DE3713757A1 (de) | Benzolsulfonamidderivate und verfahren zu ihrer herstellung | |
EP0035641B1 (de) | Cysteinderivate, Verfahren zur Herstellung derselben und diese enthaltende Arzneimittel | |
EP0080718B1 (de) | Inter-m-Phenylen-PGI2-Derivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Präparate | |
DE4115540A1 (de) | Verfahren zur herstellung von 2,2-di-(methyl)-5-(2',5'-di-(methyl)-phenoxy) -pentansaeure sowie di-(halogencarbonsaeure)-ester von mehrwertigen alkoholen und verfahren zur herstellung der letzteren | |
DE2850212A1 (de) | Prostacyclinanaloge |